Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.
Press releases published on August 11, 2025
Fluent, Inc. to Attend 45th Annual Canaccord Genuity Growth Conference
GlobeNewswire
·
August 11, 2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT), a leader in commerce media, today announced that Don Patrick, Chief Executive Officer, will attend the 45th Annual Canaccord Genuity Growth Conference on Wednesday, August 13, 2025, …
SEALSQ Unveils SEALQuantum.com Innovation Lab Progress, Expanding into AI to Anticipate the Convergence with Quantum and Cybersecurity
GlobeNewswire
·
August 11, 2025
Geneva, Switzerland, Aug. 11, 2025 (GLOBE NEWSWIRE) -- With a total $30 Million investment capacity, SEALSQ shares strategic updates on ColibriTD and IC’Alps SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a leading provider of Semiconductors, PKI, …
EverQuote Announces $21 Million Repurchase of Shares from Link Ventures and Affiliated Entities Controlled by Chairman and Co-Founder, David Blundin
GlobeNewswire
·
August 11, 2025
Enables EverQuote to efficiently execute a portion of its $50 million Share Repurchase Program Mr. Blundin remains EverQuote’s Chairman and largest shareholder CAMBRIDGE, Mass., Aug. 11, 2025 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading …
General Timothy Ray, USAF (ret) Joins Critical Metals Corp’s Advisory Board
GlobeNewswire
·
August 11, 2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced that General Tim Ray, USAF (ret) joined the Company’s newly formed …
Mevolaxy Announces Its Market Shift from DeFi Farming to MEV Staking
GlobeNewswire
·
August 11, 2025
Los Angeles, CA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Mevolaxy today announced its strategic positioning as a leading player in the accelerating transition from DeFi farming to advanced MEV staking strategies. With blockchain automation and more sophisticated …
Full Alliance Group’s Qubitera Holdings Expands Quant Blockchain Healthcare Development Roadmap
GlobeNewswire
·
August 11, 2025
TAMPA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) announced today that its subsidiary, Qubitera Holdings Inc., has released a comprehensive five-phase technical roadmap to deploy a post-quantum cryptography (PQC)-based …
Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025
GlobeNewswire
·
August 11, 2025
COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results …
CervoMed Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 11, 2025
Reported 32-week data from Phase 2b RewinD-LB Trial Extension phase showing neflamapimod treatment resulted in a substantial reduction in clinically significant worsening compared to control arm over 32 weeks, which improved further among patients who have …
vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin
GlobeNewswire
·
August 11, 2025
HIGH POINT, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being investigated …
Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results
GlobeNewswire
·
August 11, 2025
- Released positive topline data from the VIRAGE Phase 2b study of VCN-01 (zabilugene almadenorepvec); expanded data to be presented at the European Society for Medical Oncology (ESMO) 2025 Congress in October - - VCN-01 demonstrates potential in …
GBT Technologies Intends to Rebrand as Wertheim & Company; Craig Marshak Appointed CEO; Emil Assentato Joins as Strategic Investor
GlobeNewswire
·
August 11, 2025
WEST HOLLYWOOD, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC Pink: GTCH) (“GBT” or the “Company”) today announced its intention to change its corporate name to Wertheim …
4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
GlobeNewswire
·
August 11, 2025
4D-150 Phase 3 program in wet AMD advancing ahead of plan, with expected 4FRONT-1 data readout accelerated to H1 2027 from H2 2027 and 4FRONT-2 initiated ahead of schedule Presented positive 60-week results from 4D-150 SPECTRA clinical trial in DME …
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del segundo trimestre de 2025
GlobeNewswire
·
August 11, 2025
- Se han publicado datos preliminares positivos del estudio de Fase 2b de VIRAGE de VCN-01 (zabilugene almadenorepvec); los datos ampliados se presentarán en el Congreso de la European Society for Medical Oncology (ESMO) de 2025 que tendrá lugar en octubre …
Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
August 11, 2025
CONSHOHOCKEN, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the Canaccord Genuity 45th Annual Growth Conference on Tuesday, Aug. 12, 2025 at 10:30 A.M. EDT. The …
Dynacor annonce ses résultats du deuxième trimestre 2025 et poursuit la mise en œuvre de son plan d’expansion à l’international
GlobeNewswire
·
August 11, 2025
MONTRÉAL, 11 août 2025 (GLOBE NEWSWIRE) -- Dynacor Group Inc. (TSX-DNG) (“Dynacor” ou la “Société”) a annoncé aujourd’hui ses résultats financiers et opérationnels1 pour le deuxième trimestre clos le 30 juin 2025, ainsi que la réalisation d’étapes clés de …
IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (Pembrolizumab) for the Treatment of First-line Advanced Melanoma, but Statistical Significance Narrowly Missed
GlobeNewswire
·
August 11, 2025
Patients treated with Cylembio (imsapepimut and etimupepimut, adjuvanted) plus pembrolizumab achieved improvement in progression free survival (PFS) compared to patients treated with pembrolizumab monotherapy, HR=0.77 (CI 0.58-1.00), (p=0.056), with median …
Dynacor Reports Q2-2025 Results and Advances International Expansion Plan
GlobeNewswire
·
August 11, 2025
MONTREAL, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Dynacor Group Inc. (TSX: DNG) (“Dynacor” or the “Corporation”) today announced its unaudited financial and operational results1 for the second quarter ended June 30, 2025, and achievement of key milestones for …
Jupiter Neurosciences Introduces Nugevia™ MND: A Cognitive Health Supplement Leveraging Clinically Validated Neuroscience
GlobeNewswire
·
August 11, 2025
MND combines proprietary resveratrol-based platform and NovaSOL® Curcumin to enhance cognitive performance and support neuroprotective health Jupiter, Florida, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the " …
Wearable Devices Secures U.S. Patent for Groundbreaking Neural Interface Technology
GlobeNewswire
·
August 11, 2025
Granted Patent Covers Neural Measurement of Weight, Torque and Force with Broad Applications in Brain-Computer Interfaces, Industry 4.0 and Extended Reality YOKNEAM ILLIT, ISRAEL, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “ …
RedCloud Delivers Stellar Year-Over-Year Customer Growth In H1 With Positive Retailer Purchasing Behavior
GlobeNewswire
·
August 11, 2025
LONDON, Aug. 11, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (“RCT”) (“RedCloud” or the “Company”) today announces positive year-over-year customer growth numbers across its markets with a growing appetite for bulk trade between distributors, while …